Andrew Lister

Andrew Lister is an Associate Director in Medicinal Chemistry Oncology at AstraZeneca, where they are focused on delivering innovative solutions in challenging areas of research. A master's graduate from the University of York, Andrew has a substantial background in synthetic organic chemistry, having played a crucial role in advancing three compounds to clinical development. Their previous experience includes positions at GlaxoSmithKline, Evotec, and Novartis, where Andrew demonstrated expertise in managing teams and collaborating across functions to drive project success. Throughout their career, they have consistently excelled in problem-solving and meeting demanding timelines in pre-clinical chemistry.